Evaluation and Assessment for Communicable Diseases in Migrants Hosted in Reception Centers

Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Study ID
NCT07487506
Status
Recruiting
Apply to this trial

Conditions

  • Infections

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Medical history, measurement of vital signs and weight, Blood sample for blood testing, Collection of urine and collection of stool for a coproparasitological examination — DIAGNOSTIC_TEST
    * Intake and Information * Obtaining informed consent: Each participant will sign the informed consent form and data processing consent form, ensuring the voluntary nature of the screening * Conducting the screening: All migrants will undergo, on a single occasion: * Medical history: travel history, focused primarily on identifying the migration route; recent and past medical history, including both physiological and pathological aspects, with the aim of identifying risk factors, signs, and symptoms of major communicable and non-communicable diseases; * Measurement of vital signs (blood pressure, oxygen saturation, heart rate) and weight; * Physical examination; * Blood draw for the following tests: complete blood count with differential, ALT, creatinine + eGFR, urea, blood glucose; * Urine collection for a complete urinalysis and a urological parasitological examination; * Stool collection for a coprological parasitological examination

Study Details

A single-centre, non-profit experimental clinical trial. The aim of the study is to estimate the prevalence of a range of infections and infectious diseases in a cohort of asylum seekers staying in initial reception centres, who have been in Italy for at least 2 months but no more than 36 months. The infections of interest are: latent tuberculosis and active tuberculosis, HIV, HBV, HCV, syphilis, strongyloidiasis, schistosomiasis, filariasis, and intestinal helminthiasis.

Key Dates

First listed
Mar 23, 2026
Start date
Apr 8, 2025
Status verified
Mar 2026
Primary completion
Sep 8, 2026
Completion
Sep 8, 2026

Study Design

Enrollment
250 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Screening Cohort
    Screening for: * Tuberculosis * Syphilis * HIV * HBV * HCV * Intestinal helminthiasis * Strongyloidiasis * Schistosomiasis * Filariasis

Primary Outcome Measure

Prevalence of infections and infectious diseases [ Time Frame: At baseline ]

Central Contacts

Related Studies